Replies to post #129400 on Kraig Biocraft Laboratories Inc (KBLB)

[bananarama]

"The valuation I use is market driven."

And that is the issue. The market has yet to catch up to the KBLB story, but it will. I remember a time when tech stocks were the darlings of Wall Street. Dividend paying stocks, like utilities and consumer product stocks, were dead. This went on for a number of years. Suddenly, the market changed, and dividend stocks came roaring back.

Not enough important milestones have been met yet to get the attention of the market. There will come a time when the KBLB story is well-known, and that is when the PPS will take off. Two of my brokers are aware of KBLB, but they are unable to recommend it due to its lack of earnings. Once earnings appear, the market will assign KBLB a PE. That is when those two brokers can recommend the stock.

This is what I call anticipation. It is coming....